We are a highly experienced team skilled in strategy, client service, creative development and project management who share one common goal. We want our clients (big and small) to be as passionate about working with Healthwise as we are about working on their business.
Over the years, we have had the privilege of working with numerous pharmaceutical companies, hospitals, healthcare-related government organizations, professional associations and not-for-profits.
We've spent 30 years mastering one thing: translating complex science into marketing initiatives that drive results. With 80+ product launches and over 130 brands under our belt, we've built deep expertise in the pharmaceutical and biotech landscape.
Our independent, Canada-based structure means we're agile enough to pivot strategies in real-time while maintaining the scientific rigor that pharmaceutical marketing demands. We don't just understand PAAB compliance—we navigate the entire Canadian regulatory landscape (Health Canada, PAAB, Ad Standards) while delivering comprehensive digital campaign management across multiple channels.
What really sets us apart? We embrace the tough stuff. Biologics, specialty drugs, rare diseases — bring us the science, the difficult to explain, the complex mechanisms of action. That's where we turn complexity into impact.
Every drug launch campaign is different, but our approach remains consistent: strategic planning from pre-launch through post-launch optimization.
Pre-Launch Phase: We analyze market dynamics, assess competitive positioning, and map stakeholders to identify your opportunities. Our team develops your brand architecture, messaging hierarchy, and regulatory strategy—ensuring PAAB preclearance is built into timelines from day one.
Launch Execution: We create omnichannel pharmaceutical campaigns that coordinate messaging across multiple touchpoints—from HCP engagement and advisory board materials to patient education programs and digital advertising. We deliver data-driven strategies with continuous testing and optimization.
Post-Launch: We monitor campaign performance across all channels, optimize based on real-world data, and develop market access support materials for payer conversations. Whether you're launching into a niche market or a highly crowded category, we support brands throughout their whole product lifecycle, in a variety of therapeutic areas.
Regulatory compliance isn't an afterthought—it's embedded in everything we do. Our account leads have over 20+ years of experience and have evolved our approach with the changing regulations.
Our team understands the nuances of the PAAB Code, Schedule A disease restrictions, and DTC vs. HCP engagement and advertising requirements. We know how to balance regulatory constraints with creative and innovative ways to connect with audiences, within the rules.
This extends across all channels: pharmaceutical digital marketing (paid search, paid social, programmatic, HCP platforms), traditional media, sales materials, and patient education. We've managed campaigns for a diverse range of clients in the life sciences—from global leaders like Novo Nordisk, AbbVie, GSK, and AstraZeneca, to emerging innovators shaping the Canadian market—where one compliance misstep could delay a launch or damage brand reputation..
We develop high-impact marketing campaigns with clear strategic objectives, ensuring regulatory compliance through PAAB preclearance, platform restrictions, and privacy regulations—reducing revisions while maintaining creative strength.
Absolutely—Biologics marketing and specialty drug commercialization demand the highest level of scientific translation. While we apply clear, audience-focused messaging throughout every project and brand, biologics push this skill to its limit with intricate mechanisms of action, niche patient populations, and layered stakeholder needs.
Over the years, we've developed deep expertise in:
For specialty pharmaceutical marketing, we don't just create campaigns—we build ecosystems. This includes disease awareness initiatives for rare conditions, HCP education on novel mechanisms of action, patient journey mapping from diagnosis through treatment adherence, and pharmaceutical market access materials for payer negotiations.
We turn complex clinical data into strategic positioning, translate scientific advantages into market differentiation, and develop campaigns that drive brand adoption in competitive therapeutic landscapes.
We've built deep expertise in integrated omnichannel pharmaceutical marketing in Canada, because HCPs and patients don't experience channels in isolation—they move fluidly across digital and traditional touchpoints.
We start by mapping where your audiences actually are and how they make decisions, what allow us to build campaigns where each channel plays a specific role in moving them forward:
The key difference in our campaign pharma strategy? We don't just coordinate channels—we attribute results across them. We track which touchpoints drive conversions, then optimize budget allocation accordingly. We test everything: audiences, platforms, placements, creative, landing pages, conversion paths.
This data-led approach has delivered results for major pharmaceutical brands, taking their campaigns from standard industry performance to innovation that consistently exceed industry benchmarks.
Patient-centric pharmaceutical marketing has evolved from a buzzword to a business imperative. We integrate patient insights into every stage—from pre-launch brand positioning and market preparation through post-launch adherence programs.
Our patient engagement programs include:
Every pharmaceutical patient education initiative we create balances empathy with scientific accuracy, always maintaining regulatory compliance while addressing real patient needs.
Yes—our expertise extends to medical device marketing and health technology promotion. While pharma is our core strength, we've applied the same scientific rigor to marketing diagnostic devices, surgical equipment, and digital health technologies.
Medical device campaigns require similar regulatory navigation (Health Canada approval messaging, evidence-based claims) while often allowing more creative flexibility than Schedule A pharmaceutical advertising. We develop:
Our approach? The same scientific storytelling that makes us effective with complex biologics translates perfectly to explaining innovative medical technologies.
Both—our pharmaceutical marketing consulting spans strategic support through hands-on execution.
Some clients engage us as pharma strategy consultants to audit existing programs, identify optimization opportunities, and develop comprehensive marketing roadmaps. Others need full-service agency support for end-to-end campaign management.
Our pharma consulting services include:
The key is flexibility. As an independent, agile agency, we scale our involvement to match your needs—from strategic consulting through full campaign execution.
Healthcare professional engagement has fundamentally changed. The days of relying solely on rep visits are over—modern HCP marketing demands sophisticated multichannel strategies.
Our approach to physician marketing and medical professional targeting:
We understand that HCP engagement strategies must balance commercial objectives with educational value. Our programs are designed to inform, not just promote—building lasting relationships with healthcare professionals.
Over 30 years and 80+ product launches, we've delivered measurable results across every major therapeutic category.
The numbers tell part of the story:
We bring data-driven pharmaceutical marketing that continuously optimizes based on real performance—not assumptions. We test everything, measure everything, and optimize everything.
